esophagus, like the mouth, is lined with a mucosal squamous epithelium.
During critical illness, swallowing can be severely affected by anatomic disruption (such as the placement of an endotracheal tube), neurologic illnesses, and medications. Alterations of swallowing is known as dysphagia and can lead to the aspiration of saliva (and the bacteria contained in the mouth), refluxed acid secretions from the stomach, and aspiration of ingested food into the airway; aspiration remains a significant cause of morbidity in the critically ill patient.
The stomach serves as a temporary repository of food, as well providing for the initial steps of digestion. Passage of chime-the mixture of food and GI secretions-into the duodenum is permitted by the pylorus.
The majority of nutrient absorption occurs in the small bowel, composed of the duodenum, jejunum, and ileum. The absorptive surface of the small bowel is significantly increased by villi ( Fig. 17.1 
) (1).
The colon is composed of four portions, the ascending, transverse, descending, and the sigmoid colon. The colon is lined by a columnar epithelium with an abundance of goblet cells, cells that generate large amounts of mucous and are essential for the prevention of invasion of microorganisms in and through the intestinal wall. The last portions of the GI tract include the rectum and anus which provide sensitivity and continence to the presence of stool and flatus.
The mucosal lining of the entire GI tract is constantly renewed. In the small intestine and in the colon, mucosal cells arise from the crypts of Lieberkühn where pluripotent stem cell reside and can give rise to mature epithelial cells. The majority of the cells in the small bowel are mature enterocytes (absorptive cells). Goblet cells are cells that produce mucous and are particularly frequent in the colon. Paneth cells are long-lived cells localized in the small bowel with higher concentrations in the ileum. These cells play highly important antimicrobial roles through the secretion of antimicrobial peptides. Neuroendocrine cells, as their name implies, secrete a variety of hormones and interact with the autonomic nervous system. Tuft cells, relatively infrequent in number, play interesting roles in antigen "sampling" through guanine nucleotide-binding receptors (see below: The Immune System of the Gastrointestinal Tract) (2) .
Gastrointestinal Functions
The GI tract provides four basic functions:
1. It serves to break down food, digest, and absorb nutrients (3). 2. A complex system of neuroendocrine functions that carefully regulates local and systemic metabolism in response to food, interacting with other organs and systems. 3. Starting from lymphoid tissues in the mouth and the hypopharynx, specialized immune cells and organs are distributed throughout the entire GI tract, providing us protection from infection, while allowing (tolerating) the growth and proliferation of a healthy microbiome. 4. A healthy microbiome is essential for health, establishing a symbiotic relationship that permits the survival and growth of hundreds of bacterial species that live in the lumen but do not invade the walls of the GI tract.
Digestion and Absorption
The primary function of the GI tract is to process food, breaking it down mechanically and then, through digestion, convert it into the different substrates that are absorbed and subsequently serve all metabolic processes within the body. The mouth actively participates in the selection of the appropriate quantity and quality of food. Digestion also starts in the mouth with the secretion of amylase and initial breakdown of carbohydrates. In the stomach, the secretion of hydrochloric acid (HCl) by specialized parietal cells and pepsin by chief cells are essential for the initial digestion of protein into peptides.
The acid environment also nearly sterilizes ingested food. Further digestion occurs in the duodenum where chyme mixes with bile and exocrine pancreatic secretions. The acid pH of chyme coming from the stomach is neutralized post pylorus by the secretion of bicarbonate. Completion of digestion occurs in the brush border of the small bowel mucosa. In addition, the secretion of fluid into the small bowel dilutes chyme to create an isotonic fluid. Absorption of digested nutrients proceeds in the small bowel, starting proximally in the duodenum with the absorption of iron, proceeding with the absorption of amino acids, dipeptides, and tripeptides; lipids are broken down by lipases liberating mono-and diglycerides and essential fatty acids, which are surrounded by biliary salts to generate chylomicrons, which are absorbed in the distal ileum. Vitamin B 12 is also absorbed in the ileum.
The volume of fluid secreted by the GI tract during digestion can be as high as 9 L; absorption of large amounts of this fluid is initiated in the small bowel. The ascending and transverse colon provide a large amount of absorption of fluid and electrolytes so that only a few 100 mL of water are evacuated in the stool.
Neuroendocrine Regulation
A normally functional GI tract has to be able to sense the amount and quality of the food, determine the rate of progression of the food bolus through the GI tract, communicate with other organs in the body to create the necessary metabolic and physiologic responses to a meal. To do this, highly specialized communication systems with distinct but overlapping functions had to be created.
The central and autonomic nervous systems interact with all anatomic and physiologic sites of the GI tract. For one, conscious issues of hunger and satiety, thirst and the desire for specific nutrients (water, sugar, lipids, salt, and others), which may appear as volitional and hedonistic brain functions, are a result of a careful interaction with the GI tract. Classic examples demonstrate an increase in salivation and release of gastric juices in response to a visual stimulus. Satiety is in part governed by hormones such as ghrelin and GLP1 providing another example for this interaction.
Mechanical progression of food and chyme is determined by peristaltic waves which, while promoting mixing of food and GI secretions, provide a measured aboral "wave" from the GI tract; peristalsis is governed by the autonomic nervous system.
The secretion of digestive enzymes is modulated by hormones secreted by specialized cells in the GI tract. In the stomach, gastrin produced by G cells increases the secretion of pepsin and HCl. In the pancreas, secretion of secretin increases the release of bicarbonate-rich pancreatic juice. Cholecystokinin increases the secretion of bile by the liver and contractility of the gallbladder.
Governing the communication between food, the GI tract, and the rest of the body are chemical messengers with different functions. Attempts to classify these messengers are difficult due to the constant growth and discovery of different substances and also to the overlapping functions of some of these. Nonetheless, a simple classification suggests the following categories:
1. Endocrine mediators (hormones). GI hormones are peptides released into the circulation generating local and 
The Immune System of the Gastrointestinal Tract
Diverse immune tissues are distributed across the entire GI tract where they play significant role in the prevention of invasion by microorganisms. Equally as important, proper immune function creates tolerance against antigenic stimuli that come from food and from symbiotic microorganisms, preventing autoimmune responses and self-injury. The immune system in the GI tract is modulated by nutrients such as vitamin A, by antigens of the microorganisms, and by bacterial products such as short-chain fatty acids. Immune cells are not equally distributed across the GI tract with significant and dramatic variations in concentrations of cells from organ to organ. Thus, for example, the largest concentration of Th17 cells are located preferentially in the duodenum and jejunum. In contrast, the gut-associated lymphoid tissues (GALT) are preferentially distributed in the distal jejunum, ileum, and cecum. This suggests that there are highly different biologic roles in this distribution, which we are only beginning to delineate (1, 3) .
The GALT deserves special attention. In the distal small bowel, the GALT is organized in histologically distinct zones called Peyer patches. These contain numerous B-lymphocyte follicles which are flanked by smaller T-cell zones. The Peyer patches appear to be the main source of immunoglobulin A (IgA) in the small bowel. In addition, T lymphocytes are distributed across the intestine. Lymphocytes localized at the basement membrane between enterocytes and are called intraepithelial lymphocytes (IELs), and have a wide variety of regulatory and effector activities. Most frequently, IELs are T lymphocytes and are broadly divided into two categories: conventional (type A IELs) and unconventional (type B IELs).
Both helper T cells (CD4+) and cytotoxic T cells (CD8+) are observed in the lamina propria. Most of these T-cell subsets display a memory T phenotype possibly in response to the constant antigenic "sampling" that occurs at the level of the mucosa.
Of Disruption of immune responses are independent causative factors of illness. Such is the case of the inflammatory diseases such as celiac disease, Crohn disease, and ulcerative colitis.
The Gut Microbiome
Central to maintaining normal function of the GI tract is a healthy microbiome. While a microbiome exists all the way from the mouth to the anus, the duodenum and jejunum are nearly sterile. The microbial flora in the mouth and colon are distinct from each other and each one contains hundreds to over a thousand distinct bacterial and viral species and archaebacteria. Protozoa and helminths may also exist, although it is only recently that the role of these organisms in the maintenance of health for the overall microbiome has been recognized. Of all microbiomes the colonic microbiome has currently garnered the most interest.
Technologic advances using the tools of molecular biology have permitted a more complete and diverse mapping of the microbiome than otherwise could be afforded by attempting isolated cultures. In 2010, initiatives in the United States and in Europe created a complete mapping of the microbiome in distinct healthy individuals from different geographic, cultural, and genetic backgrounds. In these samples, over 750,000 distinct genes have been identified; thus, our microbiome contains multiple times more genes than our own cells (4) .
Neither the type nor the proportion of bacteria is shared by all individuals. There is also an individual variation in the proportion of bacteria in a given individual in response to dietary changes, although there is a striking stability in bacterial species in a given individual across time.
A healthy microbiome exists in a symbiotic relation with its host that involves the creation of a "tolerant" immune response. The host provides food for bacteria, of which dietary fiber is particularly important. The host also provides for a healthy "temperature and oxygen-controlled" environment. In turn, the microbiome generates important nutrients such as short-chain fatty acids, and other micronutrients that feed the gut mucosa and can be absorbed and distributed systemically.
Disruption of the microbiome can occur as a result of multiple conditions. Acute and chronic alterations can occur as a result of diet. These alterations have been linked to obesity, cardiovascular diseases, and inflammatory bowel diseases such as Crohn disease. Acute disruption of the microbiome associated with antibiotic use causes GI intolerance in acute illness and diarrhea. Clostridium difficile colitis constitutes a classic illness associated with a disrupted microbiome, and is now being managed with interventions aimed at restoring microbial homeostasis.
sPecIFIc dIsorders

Acute Pancreatitis
Acute pancreatitis, a disease process with a wide spectrum of clinical presentations and causes, can challenge any critical care physician. Only 10% to 15% of cases are severe enough to threaten patient survival, and these, therefore, likely involve the critical care physician. Gallstones and alcohol intake cause 85% of the cases of acute pancreatitis (5); the risk in heavy drinkers who also smoke heavily is increased fourfold. Other causes include hyperlipidemia, viral infections, and certain drugs such as propofol (6) (7) (8) (Table 17 .1).
Of special importance to intensivists is the association between propofol, a medication commonly used for sedation of critically ill patients, and the presence of hypertriglyceridemia and acute pancreatitis. Devlin et al. (6) retrospectively studied 159 patients in the intensive care unit (ICU) with propofol sedation, finding that 29 (18%) patients developed hypertriglyceridemia and, among these 29 patients, three presented a clinical picture of acute pancreatitis. Their final recommendation was to monitor the serum triglycerides levels and pancreas enzymes after 48 hours on propofol.
The diagnosis of acute pancreatitis requires two of the following three criteria: (1) Abdominal pain consistent with acute pancreatitis; (2) pancreatic enzyme elevation to greater than three times the upper limit of normal; and (3) findings characteristic of acute pancreatitis on contrast-enhanced computed tomography (CT) of the abdomen (9) . Thus, the usual initial workup for a patient with symptoms consistent with acute pancreatitis is to obtain serum amylase and lipase values and, generally, obtain an abdominal CT (see below). Severity of the disease may be defined using the guidance of the revised Atlanta criteria (Table 17. 2). Note, however, that the degree of enzyme elevation at admission does not necessarily forecast eventual disease severity (10) .
Acute pancreatitis due to pancreatic duct obstruction-as from a gallstone obstructing the duct-triggers the activation of endogenous pancreatic enzymes such as trypsin, causing autolysis and activation of the inflammatory response which may progress to organ failure (11) . Alcohol-induced pancreatitis is more complex, inducing acinar cell dysfunction that leads to precipitation of secretions in the ducts, obstructing outflow (12) .
Bacterial seeding of necrotic pancreatic tissue can occur, most probably through bacterial translocation (BT) from the gut, and may lead to sepsis and delayed death (13); a severe aseptic inflammatory response to pancreatitis may be difficult to differentiate from a septic response due to bacterial contamination. Ideally, in all cases of severe acute pancreatitis, the extent of necrosis should be determined using the gold standard to make such determinations, contrast-enhanced CT. Furthermore, the CT can identify other life-threatening causes of SIRS and shock not uncommonly seen in such critically ill individuals, such as major bleeding and/or hollow viscus erosion/perforation.
After the first 2 to 4 weeks of the disorder it is often seen that initially sterile peripancreatic inflammatory fluid collections coalesce into structures known as pseudocysts, which often regress spontaneously, but may persist and become infected, warranting drainage. The patient may show a persistent inflammatory state, and can deteriorate with SIRS, sepsis, or septic shock. Although the presence of air bubbles in the pancreas on abdominal CT scan suggests infection, the gold standard to rule out this possibility is CT-guided needle aspiration of the necrotic pancreatic bed. Intervention, however, is not without hazard: "routine" drainage of pancreatic fluid collection often leads to infection in previous sterile collections (14) , and thus the suspicion of infection must be convincing before intervention for drainage is undertaken. A variety of modalities of treatment exists to address infected fluid collections, ranging from percutaneous drainage to endoscopic procedures to minimally invasive or open necrosectomy. Studies of patients managed with percutaneous procedures have shown varying results (15) . Transgastric drainage guided by endoscopic ultrasound is ideal in certain clinical situations (15) , and may compare favorably with surgical intervention as experience develops (16) . Surgical choices include the socalled VARD (video-assisted retroperitoneal debridement) technique with single or repeated procedures for removal of necrotic pancreatic tissue, or open complete necrosectomy with drain placement and continuous irrigation in the postoperative period (17) . Clearly, with this variety of choices available for treatment, the decision for optimal treatment of a specific patient with acute pancreatitis must be individualized. 
Clostridium difficile Colitis
The selective pressure of antibiotic use may lead to the disruption of normal fecal flora allowing the emergence of resistant organisms and causing disease. Best known of these organisms is C. difficile, which can cause diarrheal outbreaks in health care institutions. The emergence of a hypervirulent strain of C. difficile known as NAP1/B1/ribotype 027 which produces both toxins A and B-and is frequently fluoroquinolone-resistant-has been a problem of particular importance in ICUs in many countries. C. difficile colitis can be a lethal disease particularly if treatment is delayed or inadequate. There is an increased risk of developing severe C. difficile colitis in the chronically ill, the elderly, and immunosuppressed patients. Early identification and treatment are critical, and the presence of significant leukocytosis should trigger the possibility of such a diagnosis. The severity of disease ranges from asymptomatic carriage, through diarrhea that is mild in frequency and severity, up to a fulminant and rapidly progressive toxic state with profound leukocytosis, hypotension, hypoalbuminemia, and lactic acidosis; the latter condition warrants the most aggressive treatment regimen which often includes emergent surgery (18) . Significant abdominal findings warrant radiologic investigation. An initial abdominal radiograph-a KUB (kidney, ureters, and bladder) study-may reveal significant small intestinal or colonic dilatation with pneumatosis in the colonic wall; abdominal CT scan is useful to assess colon integrity and to rule out other pathologies. Definitive diagnosis can be made using one of a variety of laboratory tests. However, the selected test should only be performed in individuals with diarrhea so as to avoid treatment of asymptomatic carriers (19) . Combination testing designs including immunoassay for C. difficile glutamate dehydrogenase antigen followed by a rapid toxin A/B assay in screen-positive samples is a 92% accurate tactic with rapid turnaround (20) . Polymerase chain reaction testing for C. difficile toxin genes is rapid with high sensitivity and specificity (21) . It is important to remember that laboratory tests cannot distinguish between colonization and infection so it is important that diagnostic testing and treatment be made within the appropriate clinical context (22) . The current mainstay of medical treatment includes the discontinuation of the inducing antibiotics, if possible (23) and the immediate initiation of oral vancomycin and/or metronidazole-the latter given either intravenously or orally. More serious disease warrants use of high-dose oral vancomycin, vancomycin retention enemas, and possibly fidaxomicin, although the expense of this new medication may limit its availability. The reader is referred to a recent review of treatment recommendations for more detail (24) . Aggressive fluid resuscitation-guided by careful monitoring of the clinical condition and volume status-and timely surgical intervention, since this disease entity can progress rapidly to the point of need for surgery, are important to decrease mortality. Despite aggressive treatment of C. difficile infection (CDI), however, morbidity from this disease and a significant incidence of recurrence continue to be a problem. Adjunctive treatments such as dietary manipulations, the use of probiotics and toxin-binding agents, and restoration of the colonic flora through the use of fecal transplant are all treatments that are being investigated, although their exact roles are unclear (25) . Fecal microbiota transplantation, the administration of fecal flora directly to the lumen of the colon or via a nasogastric (NG) or nasojejunal (NJ) tube to replete the eradicated normal gut bacterial flora, is sometimes used; it appears to have positive effects in recurrent CDI, although with low strength evidence (26) . Effectiveness of administration via NG/NJ tube or rectally via colonoscope appears to be equal (27) . Some promising findings that warrant further study have been seen in investigations of treatment of CDI with rifampin, rifaximin, nitazoxanide, tigecycline, monoclonal antibodies, and immunoglobulins (28).
Abdominal Compartment Syndrome
Increased intra-abdominal pressures (IAP) compromising blood flow to splanchnic organs have been described in an increased percentage of patients in the ICU. Elevated IAP can have a major negative impact on the functioning of all major body systems that are vital for life (29 (33) . While this procedure can be life-saving, it is associated with considerable morbidity and mortality in both the short and long time frames.
Acute Mesenteric Ischemia
The splanchnic organs are perfused by three major arterial systems: those vessels radiating from the celiac axis (the left gastric, common hepatic, and splenic arteries) and perfusing the liver, stomach, and spleen; the superior mesenteric artery (SMA), supplying most of the small bowel and the right side of the colon; and the inferior mesenteric artery (IMA), supplying the left side of the colon, sigmoid, and superior portion of the rectum. Acute mesenteric ischemia may be caused by several conditions, such as classic arterial occlusion due to embolism (40% to 50% of cases), atherosclerosis, states of low cardiac output due to shock-including cardiogenic shock-mesenteric venous occlusion or, less frequently, arterial dissection, vasculitis, or nearby inflammatory conditions (34) .
Manifestations of acute mesenteric ischemia may range from subtle findings of mild abdominal distention and/or mild pain to those of a devastating disease process of peritonitis, hypotension, circulatory collapse, and death. Reperfusion of the splanchnic organs with restoration of circulation to the affected organs may provoke a dramatic systemic inflammatory response (35) . Difficulty in making a swift and accurate diagnosis, and in formulating and executing timely therapy, most often immediate surgical intervention, leads to staggering mortality: 60% to 80% (36) .
Physical, laboratory, and radiologic findings in the patient with acute mesenteric ischemia can be difficult to analyze accurately. The presence of severe abdominal pain with few abdominal findings on physical examination in an individual (very often elderly) with risk factors is suggestive of mesenteric ischemia, and warrants immediate and aggressive investigation of this possibility. Patients with this condition-often sedated and mechanically ventilated ICU patients-making accurate abdominal examination quite difficult. Others may present with sudden overt peritoneal signs leading to pursuit of other acute abdominal conditions and delay in diagnosis. Laboratory investigation may reveal hemoconcentration and/or an otherwise unexplained metabolic acidosis or elevated lactate suggesting that progression to bowel injury has occurred. Occasionally, brisk lower GI tract bleeding or, more subtly, heme-positive stools may be discovered. Plain abdominal films are less specific, findings ranging from normal to the demonstration of ileus, portal vein air, air in the colonic wall, or free intraperitoneal air (Figs. 17.2 and 17.3) . A contrast-enhanced abdominal CT scan is useful as it may identify the precise location of the compromised vessel (artery or vein) and the extent of visceral damage. Ominous signs such as air in the portal vein, the bowel wall, or free air in the peritoneal cavity may be seen. Bedside diagnostic laparotomy/laparoscopy is an option for patients too unstable to be moved for a radiologic study. Recently, treatment of acute mesenteric ischemia has evolved into a treatment strategy combining surgical and endovascular techniques. In suitable candidates, vascular occlusion of the SMA may be treated using catheters placed through the femoral or brachial artery to perform aspirative SMA embolectomy, SMA thrombolysis with recombinant tissue plasminogen activator (rtPA), or recanalization and stenting of the SMA. Such a procedure may be performed in combination with surgical intervention (37, 38) .
Bacterial Translocation from the Gut
The GI tract performs a variety of critical physiologic functions. One among them is the maintenance of the physiologic gut mucosal barrier, which prevents the passage of bacteriaor bacterial products such as endotoxin-into the systemic circulation (39) . It has been theorized that the failure of the GI tract to maintain its functional integrity during profound physiologic stress-as in major traumatic injuries or severe burns-may contribute to the phenomenon of multiorgan system failure (MOSF) (40) ; the exact nature of this morbid interaction, however, remains obscure (41) .
It is recognized that, once the gut undergoes a predisposing condition, such as an ischemia-reperfusion insult, bacteria and endotoxins can traverse the intestinal barrier and seed distant organs such as mesenteric lymph nodes (MLNs), solid organs, and the bloodstream, a phenomenon termed bacterial translocation. Evidence from several studies has linked BT and the systemic inflammatory response with postoperative sepsis in up to 14% of cases (40, (42) (43) (44) , although BT may only be indicative of MOSF-associated pathologic gut permeability, rather than the cause of MOSF itself in this circumstance (45) . Prevention of BT is essential, and is accomplished by careful maintenance of organ perfusion, judicious use of antibiotics, avoidance of excessive IV fluids, and the early institution of EN support (46) in preference to parenteral nutrition, although this assertion is controversial.
Extrahepatic Biliary Disease
Benign extrahepatic biliary disease (EBD) is a common reason for admission to the ICU, as it is often associated with sepsis and the inflammatory response. Epidemiologic data are startling: upward of 25 million Americans harbor gallstones, the consequences of which lead to the expenditure of more than $6 billion for medical and surgical treatment (47) . The incidence of EBD increases with age, especially in women from all ethnic groups in the United States (48); it is particularly prevalent in native North Americans (49) .
The most common form of EBD is "acute cholecystitis," resulting from cystic duct obstruction, causing increase in intraluminal pressure, venous congestion, and impairment of lymphatic drainage leading to inflammation and likely infection if unrelieved. The progression of acute inflammation of the gallbladder caused by cystic duct obstruction (50) , to more serious conditions such as cholangitis-bacterial infection complicating biliary tract obstruction (51)-or emphysematous cholecystitis-infection with gas-forming anaerobic organisms (52)-with considerable morbidity and mortality may occur with delay in surgical consultation and in patients with chronic conditions such as diabetes mellitus or immunosuppression. The main cause of EBD is the presence of gallbladder calculi.
Cholecystitis in the absence of calculi ("acalculous cholecystitis," or ACC) may be observed in those with a variety of critical conditions requiring prolonged intensive care (sepsis, major trauma, substantial life-threatening burns), and who are kept without oral intake and/or are receiving total parenteral nutrition (TPN) (53) . Usual findings are fever, hyperbilirubinemia, and right upper quadrant pain, although the only finding may be that of SIRS of obscure origin. Sepsis from acute ACC may be difficult to identify because studies such as ultrasound lose their accuracy in the critically ill (54) (55) (56) . ACC carries the risk of considerable mortality (57) .
The most appropriate initial study when EBD is suspected is bedside ultrasound of the right upper quadrant,which is rapid, noninvasive, and relatively accurate (58) . Specific signs of inflammation are thickening of the gallbladder wall to greater than 3.5 mm, and/or pericholecystic fluid. Abdominal CT scan may also be helpful in demonstrating pericholecystic fluid and tissue inflammation; the obvious serious disadvantage of CT is the need to transport the patient outside the ICU. Major and minor ultrasound and CT criteria exist which, when combined with radionuclide testing-if movement to the nuclear radiology suite is advisable in a critically ill ICU patient-usually identifies AC or ACC if the intensivist recognizes often subtle findings and aggressively pursues diagnostic investigation. Of note is that nuclear cholescintigraphy has nearly perfect sensitivity in detection of acute cholecystitis (59), superior to ultrasound and CT, logistical difficulties notwithstanding.
The standard method of surgical treatment of acute cholecystitis is presently laparoscopic cholecystectomy (60).
Alternatives to this approach, namely administration of antibiotics and analgesics, or nonsurgical but invasive procedures such as percutaneous transhepatic gallbladder drainage (PTGBD), percutaneous transhepatic gallbladder aspiration (PTGBA), endoscopic transpapillary gallbladder drainage and stenting (ETGBS), and endoscopic ultrasound-guided transmural gallbladder drainage (EUS-GBD) may be considered in the critically ill (61) . The former two radiologic procedures provide long-term or transient, respectively, decompression and drainage of material from the enflamed gallbladder without the perils of general anesthesia, theoretically an attractive option to surgery in the critically ill. A Cochrane analysis was, however, unable to determine the role of percutaneous cholecystostomy compared to surgical treatment in the clinical management of high-risk surgical patients with acute cholecystitis (62) . Procedures involving bile duct cannulation and placement of an intrabiliary pigtail drainage catheter or pigtail stent under endoscopic guidance show promising results nearly comparable to percutaneous procedures (63) . A more recently developed procedure involves an endoscopically guided transgastric transmural needle followed by guidewire placement to the gallbladder and drainage tube or stent placement, offering the advantages of utility in the high-risk patient with perihepatic ascites and avoidance of the risks of percutaneous procedures in those with marginal coagulation function (64) . As to the very critically ill patient with acute ACC, a study of 1,725 patients revealed improved outcomes with percutaneous drainage compared to surgical (laparoscopic or open) cholecystectomy (65) .
Perforation of a Hollow Viscus
Perforation of a hollow viscus with resultant intra-abdominal sepsis is a common cause for ICU admission. As such, the intensivist will frequently manage these patients who present a picture of bacterial sepsis. Patients with colonic perforation may demonstrate varying degrees of septic shock, while those with perforated peptic ulcer disease most often present initially with chemical peritonitis and progress rapidly to bacterial peritonitis with time. Surgical management is obviously integral to such a patient's care, and thus coordination between the anesthesia, surgical, and critical care teams is of great importance.
The combination of an acute abdomen with rapid deterioration of the patient's condition should warrant investigation of the possibility of a perforated hollow viscus. In those abdominal infections caused by perforation of a hollow viscus, the accumulation of infectious material may reside within a confining space adjacent to the perforated organ, such as in the left lower quadrant in the case of a perforated diverticulum in the descending colon and eventually forming into an abscess cavity if not recognized, or more widespread as with a posterior perforating peptic ulcer (66) . The emergent nature of the presentation will dictate the next step. Bedside plain abdomen films may demonstrate pneumoperitoneum (67) ; ultrasound may show, in experienced hands, pneumoperitoneum (68) . CT scan may show very small volumes of free fluid and pneumoperitoneum, identify inflammatory changes of the duodenal wall and of surrounding organs (69), or small volumes of air and spillage from colonic perforation (70) . Early source control-removal of inflammatory material-is integral to successful management of perforation-related peritonitis (71) sometimes employing a "damage control" surgical strategy in the sickest and most marginally compensated patients. Aggressive supportive and perioperative care is also crucial to optimize outcome, including proper selection of antimicrobial coverage (72) .
The Abdomen as an "Unknown Source of Sepsis"
Evaluation of the abdomen as the source of sepsis in the ICU patient is difficult, and the stakes are quite high in that mortality from blood stream infection of abdominal origin is high (73) . Clinical examination in a neurologically intact patient remains the gold standard used to rule out an acute surgical abdomen and the identification of the abdomen as a source of sepsis. This is not the case in many critically ill patients in whom neurologic impairment due to the primary disease, or resultant from sedation, abrogates good communication with the patient and a dependable clinical examination; indeed, performing a good clinical examination was not possible in 43% to 69% of patients in the ICU (74) . Frequently, the elderly (75) or patients immunosuppressed by virtue of antirejection medication for organ transplant (76) may be unable to mount an inflammatory response such that peritoneal signs sufficient to facilitate immediate recognition are present; these patients may appear only to be "getting sick" despite gross peritoneal contamination. Particularly difficult are those who have had recent previous abdominal surgery and in whom an intraabdominal septic complication could be a potential cause of critical illness.
How is one to open the "black box" of the abdomen and identify an occult source of sepsis? Several conditions-pancreatitis and mesenteric ischemia, for example-could develop during the ICU admission or may be the primary reason for presentation. The diagnostic approach in these patients is dictated by several factors including the severity of the critical illness, the availability of different diagnostic tools, and the availability of specialized consultants (Fig. 17.4 ). In patients with severe hemodynamic instability and/or marginal respiratory status, movement to radiologic suites or other diagnostic facilities may be quite difficult to accomplish safely. On the other hand, diagnostic procedures that require potentially risky (77) movement (from the standpoint of LOS but less likely mortality) from the ICU often change treatment, with a favorable risk-benefit ratio (78) . Therefore, it is important for the critical care physician to identify the available tools that can assist him or her in the timely diagnosis and management of occult abdominal sepsis.
The use of radiologic tools such as plain abdominal films, CT scan, ultrasound, and nuclear medicine imaging require careful evaluation of the risks associated with the specific study versus the benefit from the information obtained. Safety of movement "to radiology" is a major consideration, as mentioned earlier; furthermore, intravenous radiocontrast material can produce serious toxicity such as acute kidney injury, as well as discomfort and pain. The information yielded by any of the studies may be poor or lead to misinterpretation, thereby increasing morbidity; thus, we discourage the use of diagnostic tests in a "fishing expedition" mode. The studies requested must be done to answer a specific question or questions and the results provided by the study should provide the answer. Nonetheless, CT has evolved with advances in practitioner experience and progress in engineering to be taking the lead in diagnosis with great accuracy of critical abdominal causes of sepsis and need for surgical or interventional radiologic intervention (79) even when prudent judgment mandates foregoing IV contrast (80) .
Occasionally, the intensivist appeals to the surgeon to perform an exploratory laparotomy as a means to diagnose and treat intra-abdominal illness. Blind exploratory laparotomies, however, have yielded uniformly poor results, generally not identifying the source of infection, while significantly increasing morbidity or mortality (74) . Other less aggressive modes of surgical diagnostic intervention exist, though less frequently used, including diagnostic peritoneal lavage (DPL), paracentesis (81) , and bedside laparoscopy (82) . Surgical intervention in critically septic patients is often managed in stages with multiple operations, with the intensivist supporting the patient through the sequential procedures (83) .
GastroIntestInal dysmotIlIty and Intolerance
Normal GI motility permits a downstream (aboral) progression of secreted fluids and food through the GI tract. It also prevents bacterial overgrowth and provides the adequate contact of nutrients with the gut mucosa, thereby allowing digestion and absorption. Intolerance in enterally fed patients is documented at 30.5% to 33%, with higher levels of intolerance observed in critically ill patients (84, 85) . The definition of "intolerance" is somewhat subjective. In 2012 the Working Group on Abdominal Problems (WGAP) of the European Society of Intensive Care Medicine (ESICM) developed definitions for GI dysfunction (Table 17. 3) (86) . Loss of coordinated propulsive motor impulses may result in decreased digestion and absorption of food and liquids, GI intolerance, and the lack of passage of flatus or stool; this is called ileus. Ileus is therefore a functional intestinal obstruction in the absence of mechanical evidence of obstruction. Ileus, in its worse clinical presentation, is a manifestation of organ (GI) dysfunction or failure. Ileus can result in ACS, severe electrolytic disturbances, and bacterial overgrowth. Furthermore, the presence of ileus precludes successful enteral nutritional interventions. For these reasons, adequate identification of ileus is an essential aspect of care of the critical care physician.
The diagnosis of ileus is often inaccurate and is based on significant preconceptions that are frequently erroneous. For example, it is often believed that surgical intervention on the GI tract results in ileus and that, postoperatively, this patient population should be kept without oral or enteral intake.
Similar misconceptions are often observed with artificially established amounts of gastric residuals or NG outputs. Paradoxically, multiple patients are often kept without enteral intake, which only exacerbates GI dysfunction and provides an inadequate and/or inappropriate diagnosis of ileus.
Ileus must be carefully identified by radiographs and a thorough clinical assessment. Careful hydration and restoration of splanchnic blood flow through adequate resuscitation are essential. The judicious use of enteral nutritional support and avoiding prolonged time periods without enteral intake are essential to the prevention and treatment of ileus. Furthermore, the careful treatment of the cause of an ileus, such as sepsis, will often result in the spontaneous resolution of the GI process. Maintenance of fluid and electrolyte balance are also important.
enteral nutrItIon
When to Feed?
Enteral nutrition (EN) has proven to be beneficial, and should be started as soon as possible in the ICU patient, as there are multiple studies demonstrating its benefits. For example, Moore et al. (87) found that starting early enteral nutrition (EEN) significantly decreased the risk of infections (p < 0.05). In contrast, the use of TPN (TPN)-particularly when selected instead of EEN-was associated with significant harm when performed by inexperienced personnel and/or if there was inadequate patient selection. In fact, a recent meta-analysis of 18 RCTs illustrated that EN was associated with decreases in infectious complications (p = 0.004) and ICU-LOS (p = 0.0003) when compared to parenteral nutrition (88) .
The mechanisms that explain why EEN is superior to TPN are only partially understood. Routinely, patients on TPN achieve higher caloric goals than on EEN but, despite this practice, patients routinely do better in the absence of TPN. Thus, the benefits of EEN are not linked to the number of calories received by the patient. Starvation is associated with increased mucosal permeability along with increased expression of ICAM-1, favoring the migration of PMNs to the intestine wall compared with enteral-fed animals (89) . Another interesting experiment showed that adding bombesin, an analogue of gastrin-releasing peptide, can recover the GALT in mice on TPN and, indeed, preserve the immune response to infections (90) . Kudsk (91) reviewed the literature regarding EEN, finding fewer infections and better outcomes when such therapy was used. In addition, Andrad et al. (92) studied rats receiving either standard TPN or glutamine-enriched TPN. They found less BT in the group on glutamine-enriched TPN, suggesting that glutamine, an amino acid, improves the response to antigens and increases the IgA levels, as reported previously (93) . Other authors have reported that EEN prevents GALT atrophy and the development of SIRS/MOD (94) (95) (96) .
Monitoring Tolerance and Meeting Nutritional Goals
The typical critically ill patient receives less than 40% of their estimated needs (97); higher protein and calorie delivery in the ICU has been shown to significantly increase ventilatorfree days (98) . Achieving at least 80% of prescribed protein intake has been linked to improved survival (99) . Appropriate prophylaxis for and management of feeding intolerance is an important component to meeting nutrition needs in critically ill patients (100, 101) . Feeding protocols can be effective in increasing the percentage of nutrition needs delivered (97).
summary
A healthy GI tract is essential for the survival of the patient with acute/critical illness. The GI tract can be a source of severe life-threatening acute illnesses that necessitate care in an ICU setting. On the other hand critical illness associated with hemodynamic instability, sepsis, and shock can cause significant alterations in GI function. An abnormal GI tract can worsen or perpetuate a persistent inflammatory-immunosuppressive response. EN provides the healthiest and most appropriate form of nutrition in the critical care setting and should be used whenever possible. In addition to its roles in processing food, the GI tract plays other essential neuroendocrine and immunologic roles. Recently, increasing attention to the microbiome has been paid. A healthy microbiome can be severely disrupted during acute/ critical illness. Restoring microbial homeostasis may prevent complications in the ICU and help in restoring health.
• The GI tract is the single most important repository of immune tissues. The complexity is highlighted by the distribution and role of the cells of the immune system across the GI tract.
• There is an increasing awareness of the importance of the microbiome, distributed across the GI tract, in the maintenance of health and in the symbiotic relationship that exists with the host. A growing body of knowledge informs us to the importance of dysbiosis as a cause of disease and the impact of critical illness on microbiome balance.
• The classic role of processing and absorbing nutrients continues to be the main route by which patients are fed through their critical illness.
• There are important and specific roles for the different anatomic portions of the GI tract. Thus physiology of the GI can only be understood if we also understand the anatomy.
• The neuroendocrine system in the GI tract is of importance. Thus, the GI tract influences/affects the functions of distant organs/systems including the central nervous system.
